Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate; povidone; indigo carmine; lactose monohydrate - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: indigo carmine; sodium starch glycollate; lactose monohydrate; povidone; iron oxide yellow; magnesium stearate; microcrystalline cellulose - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; lactose monohydrate; povidone; iron oxide red - amaryl is indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; sodium starch glycollate; microcrystalline cellulose; povidone - indications: amaryl is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - glimepiride - tablet - 1 mg - glimepiride 1 mg

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - glimepiride - tablet - 2 mg - glimepiride 2 mg

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - glimepiride - tablet - 3 mg - glimepiride 3 mg

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - amaryl is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1)] . limitations of use amaryl should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. amaryl is contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product's ingredients [see warnings and precautions (5.2)]. - sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to amaryl. do not use amaryl in patients who have a history of an allergic reaction to sulfonamide derivatives. risk summary available data from a small number of published studies and postmarketing experience with amaryl use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarriage, or adverse maternal outcomes. however, sulfonylureas (in

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

zentiva south africa (pty) ltd - tablet - see ingredients - each tablet contains glimepiride 1,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

winthrop pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains glimepiride 2,0 mg